O	O	O	0	5	Human	Human	B-NP	JJ	B-protein	6	NMOD	B-protein
O	O	O	6	22	immunodeficiency	immunodeficiency	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	23	28	virus	virus	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	29	33	type	type	I-NP	NN	I-protein	6	NMOD	I-protein
O	O	O	34	35	1	1	I-NP	CD	I-protein	6	NMOD	I-protein
T1	B-Protein	B-Protein	36	39	Tat	Tat	I-NP	NN	I-protein	7	SUB	I-protein
O	O	O	40	51	upregulates	upregulate	B-VP	VBZ	O	0	ROOT	O
T2	B-Protein	B-Protein	52	63	interleukin	interleukin	B-NP	NN	B-protein	11	NMOD	B-protein
T2	I-Protein	I-Protein	63	64	-	-	I-NP	HYPH	I-protein	8	NMOD	I-protein
T2	I-Protein	I-Protein	64	65	2	2	I-NP	CD	I-protein	11	NMOD	I-protein
O	O	O	66	75	secretion	secretion	I-NP	NN	O	7	OBJ	O
O	O	O	76	78	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	79	88	activated	activate	B-NP	VBN	B-cell_type	15	NMOD	B-cell_type
O	O	O	89	90	T	T	I-NP	NN	I-cell_type	15	NMOD	I-cell_type
O	O	O	91	96	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	I-cell_type
O	O	O	96	97	.	.	O	.	O	7	P	O

O	O	O	99	112	Dysregulation	Dysregulation	B-NP	NN	O	8	SUB	O
O	O	O	113	115	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	116	125	cytokines	cytokine	B-NP	NNS	B-protein	2	PMOD	B-protein
O	O	O	126	134	secreted	secrete	B-VP	VBN	O	3	NMOD	O
O	O	O	135	137	by	by	B-PP	IN	O	4	VMOD	O
O	O	O	138	139	T	T	B-NP	NN	B-cell_type	7	NMOD	B-cell_type
O	O	O	140	145	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	O	146	149	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	150	154	play	play	I-VP	VB	O	8	VC	O
O	O	O	155	157	an	an	B-NP	DT	O	12	NMOD	O
O	O	O	158	167	important	important	I-NP	JJ	O	12	NMOD	O
O	O	O	168	172	role	role	I-NP	NN	O	9	OBJ	O
O	O	O	173	175	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	176	179	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	180	192	pathogenesis	pathogenesis	I-NP	NN	O	13	PMOD	O
O	O	O	193	195	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	196	200	AIDS	AIDS	B-NP	NN	O	16	PMOD	O
O	O	O	200	201	.	.	O	.	O	8	P	O

O	O	O	202	204	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	205	216	investigate	investigate	I-VP	VB	O	29	VMOD	O
O	O	O	217	220	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	221	228	effects	effect	I-NP	NNS	O	2	OBJ	O
O	O	O	229	231	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	232	237	human	human	B-NP	JJ	O	9	NMOD	O
O	O	O	238	254	immunodeficiency	immunodeficiency	I-NP	NN	O	9	NMOD	O
O	O	O	255	260	virus	virus	I-NP	NN	O	9	NMOD	O
O	O	O	261	265	type	type	I-NP	NN	O	16	NMOD	O
O	O	O	266	267	1	1	I-NP	CD	O	9	NMOD	O
O	O	O	268	269	(	(	O	(	O	16	NMOD	O
O	O	O	269	272	HIV	HIV	O	NN	O	16	NMOD	O
O	O	O	272	273	-	-	O	HYPH	O	14	P	O
O	O	O	273	274	1	1	O	CD	O	16	NMOD	O
O	O	O	274	275	)	)	O	)	O	14	DEP	O
T3	B-Protein	B-Protein	276	279	Tat	Tat	B-NP	NN	B-protein	5	PMOD	B-protein
O	O	O	280	282	on	on	B-PP	IN	O	4	NMOD	O
T4	B-Protein	B-Protein	283	294	interleukin	interleukin	B-NP	NN	B-protein	20	NMOD	B-protein
T4	I-Protein	I-Protein	294	295	-	-	O	HYPH	O	20	P	O
T4	I-Protein	I-Protein	295	296	2	2	B-NP	CD	O	26	NMOD	O
O	O	O	297	298	(	(	O	(	O	25	DEP	O
T5	B-Protein	B-Protein	298	300	IL	IL	B-NP	NN	B-protein	25	DEP	B-protein
T5	I-Protein	I-Protein	300	301	-	-	O	HYPH	I-protein	22	NMOD	I-protein
T5	I-Protein	I-Protein	301	302	2	2	O	CD	I-protein	22	NMOD	I-protein
O	O	O	302	303	)	)	O	)	O	20	NMOD	O
O	O	O	304	314	expression	expression	B-NP	NN	O	17	PMOD	O
O	O	O	314	315	,	,	O	,	O	29	P	O
O	O	O	316	318	we	we	B-NP	PRP	O	29	SUB	O
O	O	O	319	323	used	use	B-VP	VBD	O	0	ROOT	O
T6	B-Protein	B-Protein	324	326	IL	IL	B-NP	NN	B-DNA	29	OBJ	B-DNA
T6	I-Protein	I-Protein	326	327	-	-	O	HYPH	I-DNA	30	NMOD	I-DNA
T6	I-Protein	I-Protein	327	328	2	2	B-NP	CD	I-DNA	33	NMOD	I-DNA
T23	B-Entity	B-Entity	329	337	promoter	promoter	I-NP	NN	I-DNA	31	OBJ	I-DNA
O	O	O	337	338	-	-	O	HYPH	O	33	NMOD	O
T7	B-Protein	B-Protein	338	353	chloramphenicol	chloramphenicol	B-NP	NN	B-DNA	37	NMOD	B-DNA
T7	I-Protein	I-Protein	354	371	acetyltransferase	acetyltransferase	I-NP	NN	I-DNA	37	NMOD	I-DNA
O	O	O	372	382	constructs	construct	I-NP	NNS	I-DNA	34	OBJ	I-DNA
O	O	O	383	386	and	and	I-NP	CC	O	37	NMOD	O
T8	B-Protein	B-Protein	387	389	IL	IL	I-NP	NN	B-protein	40	NMOD	B-protein
T8	I-Protein	I-Protein	389	390	-	-	B-NP	HYPH	I-protein	38	SBAR	I-protein
T8	I-Protein	I-Protein	390	391	2	2	I-NP	CD	I-protein	40	NMOD	I-protein
O	O	O	391	392	-	-	I-NP	HYPH	O	40	P	O
O	O	O	392	401	secreting	secrete	I-NP	VBG	O	40	VMOD	O
O	O	O	402	408	Jurkat	Jurkat	I-NP	NN	B-cell_line	46	NMOD	B-cell_line
O	O	O	409	410	T	T	I-NP	NN	I-cell_line	46	NMOD	I-cell_line
O	O	O	411	416	cells	cell	I-NP	NNS	I-cell_line	43	OBJ	I-cell_line
O	O	O	417	419	as	as	B-PP	IN	O	43	VMOD	O
O	O	O	420	421	a	a	B-NP	DT	O	50	NMOD	O
O	O	O	422	427	model	model	I-NP	NN	O	50	NMOD	O
O	O	O	428	434	system	system	I-NP	NN	O	47	PMOD	O
O	O	O	434	435	.	.	O	.	O	29	P	O

O	O	O	436	445	Transient	Transient	B-NP	JJ	O	2	NMOD	O
O	O	O	446	456	expression	expression	I-NP	NN	O	8	SUB	O
O	O	O	457	459	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	460	463	HIV	HIV	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	O	463	464	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
O	O	O	464	465	1	1	I-NP	CD	I-protein	7	NMOD	I-protein
T9	B-Protein	B-Protein	466	469	Tat	Tat	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	470	477	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	478	479	a	a	B-NP	DT	O	8	OBJ	O
O	O	O	480	484	five	five	I-NP	CD	O	9	NMOD	O
O	O	O	484	485	-	-	B-ADVP	HYPH	O	10	NMOD	O
O	O	O	486	488	to	to	B-PP	TO	O	11	AMOD	O
O	O	O	489	498	eightfold	eightfold	B-NP	JJ	O	14	NMOD	O
O	O	O	499	507	increase	increase	I-NP	NN	O	12	PMOD	O
O	O	O	508	510	in	in	B-PP	IN	O	14	NMOD	O
T10	B-Protein	B-Protein	511	513	IL	IL	B-NP	NN	B-DNA	19	NMOD	B-DNA
T10	I-Protein	I-Protein	513	514	-	-	B-NP	HYPH	I-DNA	19	NMOD	I-DNA
T10	I-Protein	I-Protein	514	515	2	2	I-NP	CD	I-DNA	19	NMOD	I-DNA
T24	B-Entity	B-Entity	516	524	promoter	promoter	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	O	525	533	activity	activity	I-NP	NN	O	15	PMOD	O
O	O	O	534	536	in	in	B-PP	IN	O	20	NMOD	O
O	O	O	537	543	Jurkat	Jurkat	B-NP	NN	B-cell_line	24	NMOD	B-cell_line
O	O	O	544	545	T	T	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	O	546	551	cells	cell	I-NP	NNS	I-cell_line	21	PMOD	I-cell_line
O	O	O	552	562	stimulated	stimulate	B-VP	VBN	O	24	NMOD	O
O	O	O	563	567	with	with	B-PP	IN	O	25	VMOD	O
T11	B-Protein	B-Protein	568	586	phytohemagglutinin	phytohemagglutinin	B-NP	NN	B-protein	31	NMOD	B-protein
O	O	O	587	590	and	and	O	CC	O	31	NMOD	O
O	O	O	591	598	phorbol	phorbol	B-NP	NN	O	31	NMOD	O
O	O	O	599	608	myristate	myristate	I-NP	NN	O	31	NMOD	O
O	O	O	609	616	acetate	acetate	I-NP	NN	O	26	PMOD	O
O	O	O	616	617	.	.	O	.	O	8	P	O

T12	B-Protein	B-Protein	618	620	IL	IL	B-NP	NN	B-protein	4	NMOD	B-protein
T12	I-Protein	I-Protein	620	621	-	-	I-NP	HYPH	I-protein	1	NMOD	I-protein
T12	I-Protein	I-Protein	621	622	2	2	I-NP	CD	I-protein	1	NMOD	I-protein
O	O	O	623	632	secretion	secretion	I-NP	NN	O	5	SUB	O
O	O	O	633	636	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	637	646	increased	increase	I-VP	VBN	O	5	VC	O
O	O	O	647	651	more	more	B-ADVP	RBR	O	9	AMOD	O
O	O	O	652	656	than	than	I-ADVP	IN	O	7	NMOD	O
O	O	O	657	664	twofold	twofold	I-ADVP	RB	O	6	VMOD	O
O	O	O	665	667	in	in	B-PP	IN	O	9	AMOD	O
O	O	O	668	672	both	both	O	CC	O	18	NMOD	O
O	O	O	673	679	Jurkat	Jurkat	B-NP	NN	B-cell_line	14	NMOD	B-cell_line
O	O	O	680	681	T	T	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	O	682	687	cells	cell	I-NP	NNS	I-cell_line	18	NMOD	I-cell_line
O	O	O	688	691	and	and	O	CC	O	18	NMOD	O
O	O	O	692	699	primary	primary	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	O	700	701	T	T	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	O	702	707	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	708	718	stimulated	stimulate	B-VP	VBN	O	18	NMOD	O
O	O	O	719	721	by	by	B-PP	IN	O	19	VMOD	O
O	O	O	722	735	extracellular	extracellular	B-NP	JJ	B-protein	22	NMOD	B-protein
O	O	O	736	739	HIV	HIV	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	739	740	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
O	O	O	740	741	1	1	I-NP	CD	I-protein	26	NMOD	I-protein
T13	B-Protein	B-Protein	742	745	Tat	Tat	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	746	753	protein	protein	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	O	753	754	.	.	O	.	O	5	P	O

O	O	O	755	763	Analysis	Analysis	B-NP	NN	O	4	SUB	O
O	O	O	764	766	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	767	771	mRNA	mRNA	B-NP	NN	B-RNA	2	PMOD	B-RNA
O	O	O	772	781	suggested	suggest	B-VP	VBD	O	0	ROOT	O
O	O	O	782	786	that	that	B-SBAR	IN	O	4	VMOD	O
T14	B-Protein	B-Protein	787	790	Tat	Tat	B-NP	NN	B-protein	7	SUB	B-protein
O	O	O	791	797	exerts	exert	B-VP	VBZ	O	5	SBAR	O
O	O	O	798	801	its	its	B-NP	PRP$	O	9	NMOD	O
O	O	O	802	808	effect	effect	I-NP	NN	O	7	OBJ	O
O	O	O	809	811	on	on	B-PP	IN	O	7	VMOD	O
T15	B-Protein	B-Protein	812	814	IL	IL	B-NP	NN	B-protein	12	NMOD	B-protein
T15	I-Protein	I-Protein	814	815	-	-	B-NP	HYPH	I-protein	10	PMOD	I-protein
T15	I-Protein	I-Protein	815	816	2	2	I-NP	CD	I-protein	12	NMOD	I-protein
O	O	O	817	826	primarily	primarily	B-ADVP	RB	O	12	NMOD	O
O	O	O	827	829	at	at	B-PP	IN	O	7	VMOD	O
O	O	O	830	833	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	834	849	transcriptional	transcriptional	I-NP	JJ	O	18	NMOD	O
O	O	O	850	855	level	level	I-NP	NN	O	15	PMOD	O
O	O	O	855	856	.	.	O	.	O	4	P	O

O	O	O	857	860	The	The	B-NP	DT	O	6	NMOD	O
T25,T26	B-Entity,B-Entity	B-Entity,B-Entity	861	863	NF	NF	I-NP	NN	O	6	NMOD	O
T25,T26	I-Entity,I-Entity	I-Entity,I-Entity	863	864	-	-	I-NP	HYPH	O	6	NMOD	O
T25,T26	I-Entity,I-Entity	I-Entity,I-Entity	864	869	kappa	kappa	I-NP	NN	B-DNA	6	NMOD	B-DNA
T25,T26	I-Entity,I-Entity	I-Entity,I-Entity	870	871	B	B	I-NP	NN	I-DNA	6	NMOD	I-DNA
T25	I-Entity	I-Entity	872	876	site	site	I-NP	NN	I-DNA	20	SUB	I-DNA
O	O	O	877	879	at	at	B-PP	IN	O	6	NMOD	O
O	O	O	880	889	positions	position	B-NP	NNS	O	7	PMOD	O
T27	B-Entity	B-Entity	890	891	-	-	O	SYM	B-DNA	8	NMOD	B-DNA
T27	I-Entity	I-Entity	891	894	206	206	B-NP	CD	I-DNA	13	NMOD	I-DNA
T27	I-Entity	I-Entity	895	897	to	to	B-PP	TO	I-DNA	13	NMOD	I-DNA
T27	I-Entity	I-Entity	898	899	-	-	B-NP	SYM	I-DNA	13	NMOD	I-DNA
T27	I-Entity	I-Entity	899	902	195	195	B-NP	CD	I-DNA	9	PMOD	I-DNA
O	O	O	903	905	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	906	909	the	the	B-NP	DT	O	19	NMOD	O
T16	B-Protein	B-Protein	910	912	IL	IL	I-NP	NN	B-DNA	19	NMOD	B-DNA
T16	I-Protein	I-Protein	912	913	-	-	I-NP	HYPH	I-DNA	19	NMOD	I-DNA
T16	I-Protein	I-Protein	913	914	2	2	I-NP	CD	I-DNA	19	NMOD	I-DNA
T28	B-Entity	B-Entity	915	923	promoter	promoter	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	924	927	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	928	936	required	require	I-VP	VBN	O	20	VC	O
O	O	O	937	940	but	but	O	CC	O	21	DEP	O
O	O	O	941	944	not	not	B-ADJP	RB	O	22	DEP	O
O	O	O	945	955	sufficient	sufficient	I-ADJP	JJ	O	21	PRD	O
O	O	O	956	959	for	for	B-PP	IN	O	24	AMOD	O
O	O	O	960	963	the	the	B-NP	DT	O	28	NMOD	O
T17	B-Protein	B-Protein	964	967	Tat	Tat	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	968	974	effect	effect	I-NP	NN	O	25	PMOD	O
O	O	O	974	975	.	.	O	.	O	20	P	O

O	O	O	976	979	The	The	B-NP	DT	O	2	NMOD	O
T18	B-Protein	B-Protein	980	983	Tat	Tat	I-NP	NN	B-protein	12	SUB	B-protein
O	O	O	983	984	-	-	B-VP	HYPH	O	2	NMOD	O
O	O	O	984	992	mediated	mediate	B-NP	VBN	O	5	NMOD	O
O	O	O	993	1001	increase	increase	I-NP	NN	O	3	OBJ	O
O	O	O	1002	1004	in	in	B-PP	IN	O	5	NMOD	O
T19	B-Protein	B-Protein	1005	1007	IL	IL	B-NP	NN	B-DNA	11	NMOD	B-DNA
T19	I-Protein	I-Protein	1007	1008	-	-	B-NP	HYPH	I-DNA	11	NMOD	I-DNA
T19	I-Protein	I-Protein	1008	1009	2	2	I-NP	CD	I-DNA	11	NMOD	I-DNA
T29	B-Entity	B-Entity	1010	1018	promoter	promoter	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	O	1019	1027	activity	activity	I-NP	NN	O	6	PMOD	O
O	O	O	1028	1033	could	could	B-VP	MD	O	0	ROOT	O
O	O	O	1034	1045	selectively	selectively	I-VP	RB	O	12	VMOD	O
O	O	O	1046	1048	be	be	I-VP	VB	O	12	VC	O
O	O	O	1049	1056	blocked	block	I-VP	VBN	O	14	VC	O
O	O	O	1057	1059	by	by	B-PP	IN	O	15	VMOD	O
O	O	O	1060	1069	antisense	antisense	B-NP	JJ	O	18	NMOD	O
T20	B-Protein	B-Protein	1070	1073	tat	tat	I-NP	NN	O	16	PMOD	O
O	O	O	1074	1076	or	or	O	CC	O	16	PMOD	O
O	O	O	1076	1077	-	-	B-ADJP	HYPH	O	16	P	O
O	O	O	1077	1083	unlike	unlike	B-PP	IN	O	16	PMOD	O
O	O	O	1084	1087	the	the	B-NP	DT	O	24	NMOD	O
O	O	O	1088	1097	analogous	analogous	I-NP	JJ	O	24	NMOD	O
O	O	O	1098	1104	effect	effect	I-NP	NN	O	21	PMOD	O
O	O	O	1105	1107	of	of	B-PP	IN	O	24	NMOD	O
O	O	O	1108	1113	human	human	B-NP	JJ	O	25	PMOD	O
O	O	O	1114	1115	T	T	I-NP	NN	O	34	NMOD	O
O	O	O	1115	1116	-	-	I-NP	HYPH	O	34	P	O
O	O	O	1116	1120	cell	cell	I-NP	NN	O	34	NMOD	O
O	O	O	1121	1133	lymphotropic	lymphotropic	I-NP	JJ	O	34	NMOD	O
O	O	O	1134	1139	virus	virus	I-NP	NN	O	34	NMOD	O
O	O	O	1140	1144	type	type	I-NP	NN	O	34	NMOD	O
O	O	O	1145	1146	1	1	I-NP	CD	O	34	NMOD	O
T21	B-Protein	B-Protein	1147	1150	Tax	Tax	I-NP	NN	B-protein	26	NMOD	B-protein
O	O	O	1150	1151	-	-	B-ADJP	HYPH	O	16	P	O
O	O	O	1151	1153	by	by	B-PP	IN	O	16	PMOD	O
O	O	O	1154	1165	cyclosporin	cyclosporin	B-NP	NN	O	38	NMOD	O
O	O	O	1166	1167	A	A	I-NP	NN	O	36	PMOD	O
O	O	O	1167	1168	.	.	O	.	O	12	P	O

O	O	O	1169	1172	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1173	1181	observed	observe	I-NP	VBN	O	3	NMOD	O
O	O	O	1182	1190	increase	increase	I-NP	NN	O	9	SUB	O
O	O	O	1191	1193	in	in	B-PP	IN	O	3	NMOD	O
T22	B-Protein	B-Protein	1194	1196	IL	IL	B-NP	NN	B-protein	8	NMOD	B-protein
T22	I-Protein	I-Protein	1196	1197	-	-	B-NP	HYPH	I-protein	5	NMOD	I-protein
T22	I-Protein	I-Protein	1197	1198	2	2	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	O	1199	1205	levels	level	I-NP	NNS	O	4	PMOD	O
O	O	O	1206	1211	might	might	B-VP	MD	O	0	ROOT	O
O	O	O	1212	1222	facilitate	facilitate	I-VP	VB	O	9	VC	O
O	O	O	1223	1228	virus	virus	B-NP	NN	O	10	OBJ	O
O	O	O	1229	1235	spread	spread	B-VP	VBN	O	11	NMOD	O
O	O	O	1236	1240	from	from	B-PP	IN	O	11	NMOD	O
O	O	O	1241	1243	or	or	B-PP	CC	O	13	PMOD	O
O	O	O	1244	1246	to	to	B-PP	TO	O	13	PMOD	O
O	O	O	1247	1248	T	T	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	O	1249	1254	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	O	1254	1255	.	.	O	.	O	9	P	O

O	O	O	1256	1267	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	O
O	O	O	1267	1268	,	,	O	,	O	4	P	O
O	O	O	1269	1271	it	it	B-NP	PRP	O	4	SUB	O
O	O	O	1272	1277	might	might	B-VP	MD	O	0	ROOT	O
O	O	O	1278	1288	contribute	contribute	I-VP	VB	O	4	VC	O
O	O	O	1289	1291	to	to	B-PP	TO	O	5	VMOD	O
O	O	O	1292	1295	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	1296	1318	hypergammaglobulinemia	hypergammaglobulinemia	I-NP	NN	O	25	NMOD	O
O	O	O	1319	1321	or	or	O	CC	O	25	NMOD	O
O	O	O	1321	1322	,	,	O	,	O	25	P	O
O	O	O	1323	1331	together	together	B-ADVP	RB	O	25	NMOD	O
O	O	O	1332	1336	with	with	B-PP	IN	O	25	NMOD	O
O	O	O	1337	1342	other	other	B-NP	JJ	O	14	NMOD	O
O	O	O	1343	1352	cytokines	cytokine	I-NP	NNS	B-protein	12	PMOD	B-protein
O	O	O	1353	1358	found	find	B-VP	VBN	O	14	NMOD	O
O	O	O	1359	1361	to	to	I-VP	TO	O	17	VMOD	O
O	O	O	1362	1364	be	be	I-VP	VB	O	15	VMOD	O
O	O	O	1365	1377	dysregulated	dysregulate	I-VP	VBN	O	17	VC	O
O	O	O	1377	1378	,	,	O	,	O	25	P	O
O	O	O	1379	1382	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	1383	1384	T	T	I-NP	NN	O	25	NMOD	O
O	O	O	1384	1385	-	-	I-NP	HYPH	O	25	NMOD	O
O	O	O	1385	1391	helper	helper	I-NP	NN	O	25	NMOD	O
O	O	O	1392	1396	cell	cell	I-NP	NN	O	25	NMOD	O
O	O	O	1397	1409	dysfunctions	dysfunction	I-NP	NNS	O	6	PMOD	O
O	O	O	1410	1418	observed	observe	B-VP	VBN	O	25	NMOD	O
O	O	O	1419	1421	in	in	B-PP	IN	O	26	VMOD	O
O	O	O	1422	1426	AIDS	AIDS	B-NP	NN	O	29	NMOD	O
O	O	O	1427	1435	patients	patient	I-NP	NNS	O	27	PMOD	O
O	O	O	1435	1436	.	.	O	.	O	4	P	O
